Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $0.0 | ($10.8M) | ($605.0M) | $7,696.0M | $4,828.0M | $6,603.0M | $23.3B | $30.4B | $27.6B | $32.2B | $27.1B | $78.4B | $67.6B | $54.8B | $47.3B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, AbbVie Inc.'s last 12-month Net Debt is $63.8B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, AbbVie Inc.'s Net Debt growth was 34.4%. The average annual Net Debt growth rates for AbbVie Inc. have been (5.6%) over the past three years, 17.8% over the past five years.
Over the last year, AbbVie Inc.'s Net Debt growth was 34.4%, which is higher than industry growth of 0.3%. It indicates that AbbVie Inc.'s Net Debt growth is Bad.